INVANZ Side Effects

7020815-3 | Face Oedema, Pyrexia, Rash, Stridor
on Sep 23, 2010 Male patient from UNITED STATES , child 5 years of age, was diagnosed with appendicitis (What is appendicitis?) and was treated with Invanz (View Usage). Patient experienced the following unwanted or unexpected effects: face oedema, pyrexia, rash (What is rash?), stridor. Invanz dosage: . Patient was hospitalized.

7020814-1 | Dysphagia, Swelling Face, Swollen Tongue, Urticaria
Patient was taking Invanz (View Usage). Patient had the following side effects: dysphagia, swelling face, swollen tongue, urticaria on Sep 20, 2010 from UNITED STATES Additional patient health information: Female patient , 36 years of age, was diagnosed with cellulitis (What is cellulitis?) and. Invanz dosage: . Patient was hospitalized.

7001879-X | Face Oedema, Pyrexia, Rash, Stridor
Adverse event was reported on Sep 13, 2010 by a Male patient taking Invanz (View Usage) (Dosage: ) was diagnosed with appendicitis (What is appendicitis?) and. Location: UNITED STATES , child 5 years of age, After Invanz was administered, patient had the following side effects: face oedema, pyrexia, rash (What is rash?), stridor. Patient was hospitalized.

6934726-2 | Complex Partial Seizures, Disorientation, Hallucination, Visual, Hyperhidrosis
on Aug 12, 2010 Male patient from FRANCE , 64 years of age, was diagnosed with infection (What is infection?) and was treated with Invanz (View Usage). Patient experienced the following unwanted or unexpected effects: complex partial seizures, disorientation, hallucination, visual, hyperhidrosis. Invanz dosage: . During the same period patient was treated with CEFOTAXIME SODIUM (View Cefotaxime Sodium Review and Cefotaxime Sodium Label ), TRAMADOL HYDROCHLORIDE (View Tramadol Hydrochloride Review and Tramadol Hydrochloride Label ), NEFOPAM HYDROCHLORIDE (View Nefopam Hydrochloride Review and Nefopam Hydrochloride Label ), CEFTRIAXONE SODIUM (View Ceftriaxone Sodium Review and Ceftriaxone Sodium Label ), AMIKACIN SULFATE (View Amikacin Sulfate Review and Amikacin Sulfate Label ). Patient was hospitalized.


6930620-1 | Confusional State, Hallucination, Visual, Muscular Weakness, Tremor
on Aug 13, 2010 Female patient from SPAIN , 87 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?), atrial fibrillation (What is atrial fibrillation?), cardiomyopathy (What is cardiomyopathy?), renal failure chronic and was treated with Invanz (View Usage). Patient had the following side effects: confusional state, hallucination, visual, muscular weakness, tremor. Invanz dosage: . During the same period patient was treated with ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), AMIODARONE HYDROCHLORIDE (View Amiodarone Hydrochloride Review and Amiodarone Hydrochloride Label ), FERROUS GLYCINE SULFATE (View Ferrous Glycine Sulfate Review and Ferrous Glycine Sulfate Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), METHOXY POLYETHYLENE GLYCOL EPOETIN BETA (View Methoxy Polyethylene Glycol-epoetin Beta Review and Methoxy Polyethylene Glycol-epoetin Beta Label ). Patient was hospitalized.

6930607-9 | Complex Partial Seizures, Disorientation, Hallucination, Visual, Hyperhidrosis
Patient was taking Invanz (View Usage). After Invanz was administered, patient had the following side effects: complex partial seizures, disorientation, hallucination, visual, hyperhidrosis on Aug 12, 2010 from FRANCE Additional patient health information: Male patient , 64 years of age, was diagnosed with infection (What is infection?) and. Invanz dosage: . During the same period patient was treated with CEFOTAXIME SODIUM (View Cefotaxime Sodium Review and Cefotaxime Sodium Label ), TRAMADOL HYDROCHLORIDE (View Tramadol Hydrochloride Review and Tramadol Hydrochloride Label ), NEFOPAM HYDROCHLORIDE (View Nefopam Hydrochloride Review and Nefopam Hydrochloride Label ), CEFTRIAXONE SODIUM (View Ceftriaxone Sodium Review and Ceftriaxone Sodium Label ), AMIKACIN SULFATE (View Amikacin Sulfate Review and Amikacin Sulfate Label ). Patient was hospitalized.

6929152-6 | Altered State Of Consciousness, Somnolence
Adverse event was reported on Aug 11, 2010 by a Male patient taking Invanz (View Usage) (Dosage: ) was diagnosed with pyelonephritis acute, hypercholesterolaemia, prophylaxis, gastrooesophageal reflux disease, hypertension, diabetes mellitus, prophylaxis against transplant rejection and. Location: FRANCE , 69 years of age, Patient experienced the following unwanted or unexpected effects: altered state of consciousness, somnolence. During the same period patient was treated with ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), ASPIRIN LYSINE (View Aspirin Lysine Review and Aspirin Lysine Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), INSULIN GLARGINE (View Insulin Glargine Review and Insulin Glargine Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ). Patient was hospitalized.

6929145-9 | Encephalopathy
on Aug 12, 2010 Male patient from FRANCE , 39 years of age, was diagnosed with nocardiosis, thrombosis prophylaxis, depression (What is depression?), hypertension, epilepsy (What is epilepsy?) and was treated with Invanz (View Usage). Patient had the following side effects: encephalopathy. Invanz dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), VENLAFAXINE HYDROCHLORIDE (View Venlafaxine Hydrochloride Review and Venlafaxine Hydrochloride Label ), LERCANIDIPINE HYDROCHLORIDE (View Lercanidipine Hydrochloride Review and Lercanidipine Hydrochloride Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PERINDOPRIL ARGININE (View Perindopril Arginine Review and Perindopril Arginine Label ). Patient was hospitalized.

6928355-4 | Aphasia, Facial Paresis, Muscular Weakness, Status Epilepticus
on Aug 03, 2010 Female patient from UNITED KINGDOM , 73 years of age, weighting 231.5 lb, was diagnosed with klebsiella infection, osteomyelitis and was treated with Invanz (View Usage). After Invanz was administered, patient had the following side effects: aphasia (What is aphasia?), facial paresis, muscular weakness, status epilepticus. Invanz dosage: . Patient was hospitalized and became disabled.

6923371-0 | Confusional State, Hallucination, Muscular Weakness, Tremor
Patient was taking Invanz (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, hallucination, muscular weakness, tremor on Aug 11, 2010 from SPAIN Additional patient health information: Female patient , 87 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and. Invanz dosage: . Patient was hospitalized.

6922160-0 | Aphasia, Facial Paresis, Muscular Weakness, Status Epilepticus
Adverse event was reported on Aug 03, 2010 by a Female patient taking Invanz (View Usage) (Dosage: ) was diagnosed with klebsiella infection, osteomyelitis and. Location: UNITED KINGDOM , 73 years of age, weighting 231.5 lb, Patient had the following side effects: aphasia (What is aphasia?), facial paresis, muscular weakness, status epilepticus. Patient was hospitalized and became disabled.

6914644-6 | Eosinophilia, Rash, Renal Impairment
on Aug 03, 2010 Male patient from UNITED KINGDOM , weighting 176.4 lb, was diagnosed with sepsis (What is sepsis?), empyema and was treated with Invanz (View Usage). After Invanz was administered, patient had the following side effects: eosinophilia, rash (What is rash?), renal impairment. Invanz dosage: . During the same period patient was treated with METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), PIPERCILLIN AND TAZOBACTAM (View Pipercillin And Tazobactam Review and Pipercillin And Tazobactam Label ).

6827049-3 | Pancytopenia
on Jul 02, 2010 Female patient from PORTUGAL , 70 years of age, was diagnosed with erysipelas and was treated with Invanz (View Usage). Patient experienced the following unwanted or unexpected effects: pancytopenia. Invanz dosage: . Patient was hospitalized.

6820152-3 | Hepatic Lesion, Hyperpyrexia, Jaundice
Patient was taking Invanz (View Usage). Patient had the following side effects: hepatic lesion, hyperpyrexia, jaundice (What is jaundice?) on Jul 02, 2010 from ITALY Additional patient health information: Male patient , 66 years of age, was diagnosed with abdominal abscess and. Invanz dosage: . During the same period patient was treated with ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), FUROSEMIDE SODIUM (View Furosemide Sodium Review and Furosemide Sodium Label ), CANRENOATE POTASSIUM (View Canrenoate Potassium Review and Canrenoate Potassium Label ), PANCREATIN (View Pancreatin Review and Pancreatin Label ), MAGNESIUM PIDOLATE (View Magnesium Pidolate Review and Magnesium Pidolate Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ). Patient was hospitalized.

6795631-8 | Convulsion
Adverse event was reported on Jun 14, 2010 by a Male patient taking Invanz (View Usage) (Dosage: ) was diagnosed with prophylaxis, epilepsy (What is epilepsy?) and. Location: UNITED STATES , 49 years of age, After Invanz was administered, patient had the following side effects: convulsion. During the same period patient was treated with VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ). Patient was hospitalized.

6782132-6 | Anaemia, Brain Abscess, Oropharyngeal Pain
on Jun 09, 2010 Male patient from UNITED KINGDOM , 53 years of age, was diagnosed with liver abscess and was treated with Invanz (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, brain abscess, oropharyngeal pain. Invanz dosage: . During the same period patient was treated with METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ). Patient was hospitalized.

6775428-5 | Convulsion
on Jun 07, 2010 Male patient from UNITED STATES , 49 years of age, was diagnosed with prophylaxis, epilepsy (What is epilepsy?) and was treated with Invanz (View Usage). Patient had the following side effects: convulsion. Invanz dosage: . During the same period patient was treated with VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ). Patient was hospitalized.

6770176-X | Confusional State, Delirium, Depressed Level Of Consciousness, Hallucinations, Mixed
Patient was taking Invanz (View Usage). After Invanz was administered, patient had the following side effects: confusional state, delirium, depressed level of consciousness, hallucinations, mixed on Jun 07, 2010 from CANADA Additional patient health information: Female patient , 58 years of age, weighting 260.1 lb, was diagnosed with osteitis and. Invanz dosage: . During the same period patient was treated with CLONIDINE (View Clonidine Review and Clonidine Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ). Patient was hospitalized.

6766536-3 | Dizziness, Hallucination, Nausea, Suicidal Ideation
Adverse event was reported on Jun 08, 2010 by a Female patient taking Invanz (View Usage) (Dosage: ) was diagnosed with graft infection and. Location: UNITED KINGDOM , 85 years of age, Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), hallucination, nausea (What is nausea?), suicidal ideation. During the same period patient was treated with LINEZOLID (View Linezolid Review and Linezolid Label ).

6761338-6 | Chest Discomfort, Dyspnoea
on Jun 01, 2010 Male patient from CHINA , 85 years of age, was diagnosed with lung infection and was treated with Invanz (View Usage). Patient had the following side effects: chest discomfort, dyspnoea. Invanz dosage: . During the same period patient was treated with CEFTRIAXONE SODIUM (View Ceftriaxone Sodium Review and Ceftriaxone Sodium Label ).

6744310-1 | Diarrhoea, Pseudomembranous Colitis
on May 25, 2010 Female patient from SERBIA , 63 years of age, weighting 116.8 lb, was diagnosed with therapeutic procedure and was treated with Invanz (View Usage). After Invanz was administered, patient had the following side effects: diarrhoea, pseudomembranous colitis. Invanz dosage: . During the same period patient was treated with ALBUMIN HUMAN (View Albumin Human Review and Albumin Human Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), PYRIDOXINE (View Pyridoxine Review and Pyridoxine Label ), RANISAN (View Ranisan Review and Ranisan Label ), FRAXIPARIN (View Fraxiparin Review and Fraxiparin Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ). Patient was hospitalized.

6742248-7 | Stevens-johnson Syndrome
Patient was taking Invanz (View Usage). Patient experienced the following unwanted or unexpected effects: stevens-johnson syndrome on May 21, 2010 from MALAYSIA Additional patient health information: Female patient , 65 years of age, . Invanz dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ).

6731307-0 | Cardiac Failure, Confusional State
Adverse event was reported on May 10, 2010 by a Female patient taking Invanz (View Usage) (Dosage: ) was diagnosed with diverticulitis and. Location: SPAIN , 93 years of age, Patient had the following side effects: cardiac failure, confusional state. Patient was hospitalized.

6717854-6 | Hepatic Lesion, Hyperpyrexia, Jaundice
on May 06, 2010 Male patient from ITALY , 66 years of age, was diagnosed with abdominal abscess and was treated with Invanz (View Usage). After Invanz was administered, patient had the following side effects: hepatic lesion, hyperpyrexia, jaundice (What is jaundice?). Invanz dosage: . During the same period patient was treated with ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), FUROSEMIDE SODIUM (View Furosemide Sodium Review and Furosemide Sodium Label ), CANRENOATE POTASSIUM (View Canrenoate Potassium Review and Canrenoate Potassium Label ), PANCREATIN (View Pancreatin Review and Pancreatin Label ), MAGNESIUM PIDOLATE (View Magnesium Pidolate Review and Magnesium Pidolate Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ). Patient was hospitalized.

6669156-4 | No Adverse Event, Prostatitis
on Mar 29, 2010 Male patient from UNITED STATES , 76 years of age, was diagnosed with prostatitis and was treated with Invanz (View Usage). Patient experienced the following unwanted or unexpected effects: no adverse event, prostatitis. Invanz dosage: .

6662500-3 | Convulsion, Hallucination, Muscular Weakness, Myalgia
Patient was taking Invanz (View Usage). Patient had the following side effects: convulsion, hallucination, muscular weakness, myalgia on Mar 29, 2010 from UNITED STATES Additional patient health information: Female patient , 85 years of age, was diagnosed with escherichia infection and. Invanz dosage: . Patient was hospitalized.

6648958-4 | Epilepsy
Adverse event was reported on Mar 19, 2010 by a Female patient taking Invanz (View Usage) (Dosage: ) was diagnosed with pneumonia (What is pneumonia?), asthma (What is asthma?) and. Location: CROATIA (local name: Hrvatska) , 76 years of age, weighting 79.37 lb, After Invanz was administered, patient had the following side effects: epilepsy (What is epilepsy?). During the same period patient was treated with TEOLIN (View Teolin Review and Teolin Label ), ANEPHYLLIN (AMINOPHYLLINE) (View Anephyllin (aminophylline) Review and Anephyllin (aminophylline) Label ), DIPYRONE (View Dipyrone Review and Dipyrone Label ), NEXIUM (View Nexium Review and Nexium Label ), PRINZIDE (View Prinzide Review and Prinzide Label ), CIPRINOL (View Ciprinol Review and Ciprinol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized and became disabled.

6639182-X | Confusional State, Depressed Level Of Consciousness, Muscle Rigidity, Posture Abnormal
on Mar 12, 2010 Male patient from SPAIN , 80 years of age, weighting 178.6 lb, was diagnosed with cholecystitis acute and was treated with Invanz (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, depressed level of consciousness, muscle rigidity, posture abnormal. Invanz dosage: . During the same period patient was treated with NOLOTIL (View Nolotil Review and Nolotil Label ), HEPARIN LOW MOLECULAR WEIGHT (View Heparin Low Molecular Weight Review and Heparin Low Molecular Weight Label ).

6638480-3 | Septic Shock
on Mar 11, 2010 Male patient from SPAIN , 53 years of age, was diagnosed with diverticulitis and was treated with Invanz (View Usage). Patient had the following side effects: septic shock. Invanz dosage: . During the same period patient was treated with PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM (View Piperacillin Sodium And Tazobactam Sodium Review and Piperacillin Sodium And Tazobactam Sodium Label ).

6636625-2 | Convulsion, Hallucination, Muscular Weakness, Myalgia
Patient was taking Invanz (View Usage). After Invanz was administered, patient had the following side effects: convulsion, hallucination, muscular weakness, myalgia on Mar 11, 2010 from UNITED STATES Additional patient health information: Female patient , 85 years of age, was diagnosed with escherichia infection and. Invanz dosage: . Patient was hospitalized.

6635608-6 | Confusional State, Depressed Level Of Consciousness, Muscle Rigidity, Posture Abnormal
Adverse event was reported on Mar 12, 2010 by a Male patient taking Invanz (View Usage) (Dosage: ) was diagnosed with cholecystitis acute and. Location: SPAIN , 80 years of age, weighting 178.6 lb, Patient experienced the following unwanted or unexpected effects: confusional state, depressed level of consciousness, muscle rigidity, posture abnormal. During the same period patient was treated with NOLOTIL (View Nolotil Review and Nolotil Label ), HEPARIN LOW MOLECULAR WEIGHT (View Heparin Low Molecular Weight Review and Heparin Low Molecular Weight Label ).

6626583-9 | Confusional State, Depressed Level Of Consciousness, Muscle Rigidity, Posture Abnormal
on Mar 08, 2010 Male patient from SPAIN , 80 years of age, weighting 178.6 lb, was diagnosed with cholecystitis acute and was treated with Invanz (View Usage). Patient had the following side effects: confusional state, depressed level of consciousness, muscle rigidity, posture abnormal. Invanz dosage: . During the same period patient was treated with LOPID (View Lopid Review and Lopid Label ), TICLOPIDINE HYDROCHLORIDE (View Ticlopidine Hydrochloride Review and Ticlopidine Hydrochloride Label ).

6614007-7 | Confusional State, Dysarthria, Pyramidal Tract Syndrome
on Mar 02, 2010 Female patient from PERU , 76 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Invanz (View Usage). After Invanz was administered, patient had the following side effects: confusional state, dysarthria, pyramidal tract syndrome. Invanz dosage: . Patient was hospitalized.

6612869-0 | Hepatic Function Abnormal, Renal Impairment, Stevens-johnson Syndrome, White Blood Cell Count Decreased
Patient was taking Invanz (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal, renal impairment, stevens-johnson syndrome, white blood cell count decreased on Mar 01, 2010 from TAIWAN, PROVINCE OF CHINA Additional patient health information: Male patient , 76 years of age, was diagnosed with pneumonia aspiration, parkinsonism, dementia (What is dementia?) and. Invanz dosage: . During the same period patient was treated with STALEVO 100 (View Stalevo 100 Review and Stalevo 100 Label ), BISACODYL (View Bisacodyl Review and Bisacodyl Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), DONEPEZIL HYDROCHLORIDE (View Donepezil Hydrochloride Review and Donepezil Hydrochloride Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6610249-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatitis C Positive
Adverse event was reported on Feb 23, 2010 by a Female patient taking Invanz (View Usage) (Dosage: ) was diagnosed with lyme disease, cat scratch disease (What is cat scratch disease?) and. Location: UNITED STATES , 71 years of age, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatitis c positive.

6610243-4 | Prostatitis
on Feb 24, 2010 Male patient from UNITED STATES , 76 years of age, was diagnosed with prostatitis and was treated with Invanz (View Usage). After Invanz was administered, patient had the following side effects: prostatitis. Invanz dosage: .

6602598-1 | Convulsion, Hallucination, Muscular Weakness, Myalgia
on Feb 22, 2010 Female patient from UNITED STATES , 85 years of age, was diagnosed with escherichia infection and was treated with Invanz (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, hallucination, muscular weakness, myalgia. Invanz dosage: . Patient was hospitalized.

6596751-3 | Delirium, Hallucination, Visual Impairment
Patient was taking Invanz (View Usage). Patient had the following side effects: delirium, hallucination, visual impairment on Feb 19, 2010 from FRANCE Additional patient health information: Male patient , 78 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and. Invanz dosage: . During the same period patient was treated with ESCITALOPRAM OXALATE (View Escitalopram Oxalate Review and Escitalopram Oxalate Label ), ALFUZOSIN HYDROCHLORIDE (View Alfuzosin Hydrochloride Review and Alfuzosin Hydrochloride Label ), BACLOFEN (View Baclofen Review and Baclofen Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), POLYETHYLENE GLYCOL 3350 AND POTASSIUM CHLORIDE AND SODIUM BICARBONATE (View Polyethylene Glycol 3350 And Potassium Chloride And Sodium Bicarbonate Review and Polyethylene Glycol 3350 And Potassium Chloride And Sodium Bicarbonate Label ). Patient was hospitalized.

6596745-8 | Henoch-schonlein Purpura, Renal Failure Acute, Tubulointerstitial Nephritis
Adverse event was reported on Feb 17, 2010 by a Male patient taking Invanz (View Usage) (Dosage: ) was diagnosed with osteitis, anaemia, atrial fibrillation (What is atrial fibrillation?), oedema, blood pressure (What is blood pressure?), hypertension and. Location: CANADA , 58 years of age, weighting 381.4 lb, After Invanz was administered, patient had the following side effects: henoch-schonlein purpura, renal failure acute, tubulointerstitial nephritis. During the same period patient was treated with WARFARIN SODIUM (Dose Based On Inr) (View Warfarin Sodium Review and Warfarin Sodium Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), METOLAZONE (View Metolazone Review and Metolazone Label ). Patient was hospitalized and became disabled.

6590878-8 | Hepatitis C
on Feb 09, 2010 Female patient from UNITED STATES , 71 years of age, was treated with Invanz (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis c (What is hepatitis c?). Invanz dosage: . Patient was hospitalized.

6580708-2 | Prostatitis
on Feb 03, 2010 Male patient from UNITED STATES , 76 years of age, was diagnosed with prostatitis and was treated with Invanz (View Usage). Patient had the following side effects: prostatitis. Invanz dosage: .

6569198-3 | Convulsion, Multi-organ Failure
Patient was taking Invanz (View Usage). After Invanz was administered, patient had the following side effects: convulsion, multi-organ failure on Jan 28, 2010 from FRANCE Additional patient health information: Male patient , 51 years of age, was diagnosed with mediastinitis and. Invanz dosage: . During the same period patient was treated with PRIMAXIN (View Primaxin Review and Primaxin Label ). Patient was hospitalized.

6567611-9 | Convulsion, Multi-organ Failure
Adverse event was reported on Jan 28, 2010 by a Male patient taking Invanz (View Usage) (Dosage: ) was diagnosed with mediastinitis and. Location: FRANCE , 51 years of age, Patient experienced the following unwanted or unexpected effects: convulsion, multi-organ failure. During the same period patient was treated with PRIMAXIN (View Primaxin Review and Primaxin Label ). Patient was hospitalized.

6566010-3 | Convulsion
on Jan 29, 2010 Male patient from UNITED STATES , 71 years of age, weighting 186.0 lb, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Invanz (View Usage). Patient had the following side effects: convulsion. Invanz dosage: 1 Gram Every 24 Hours Iv. Patient was hospitalized.

6558367-4 | Clostridial Infection
on Jan 21, 2010 Female patient from UNITED STATES , 41 years of age, was diagnosed with prophylaxis and was treated with Invanz (View Usage). After Invanz was administered, patient had the following side effects: clostridial infection. Invanz dosage: . Patient was hospitalized.

6552806-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased
Patient was taking Invanz (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased on Jan 21, 2010 from CANADA Additional patient health information: Female patient , 40 years of age, . Invanz dosage: . During the same period patient was treated with AMITRIPTYLINE HYDROCHLORIDE (View Amitriptyline Hydrochloride Review and Amitriptyline Hydrochloride Label ), CYCLOBENZAPRINE HYDROCHLORIDE (View Cyclobenzaprine Hydrochloride Review and Cyclobenzaprine Hydrochloride Label ), VENLAFAXINE HYDROCHLORIDE (View Venlafaxine Hydrochloride Review and Venlafaxine Hydrochloride Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), PREGABALIN (View Pregabalin Review and Pregabalin Label ), NAPROXEN (View Naproxen Review and Naproxen Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), PAROXETINE (View Paroxetine Review and Paroxetine Label ).

6551791-5 | Abdominal Pain, Clostridium Difficile Colitis, Diarrhoea, Pyrexia
Adverse event was reported on Mar 21, 2008 by a Male patient taking Invanz (View Usage) (Dosage: Iv) was diagnosed with surgery (What is surgery?) and. Location: UNITED STATES , 82 years of age, Patient had the following side effects: abdominal pain (What is abdominal pain?), clostridium difficile colitis, diarrhoea, pyrexia. Patient was hospitalized.

6551603-X | Platelet Count Decreased
on Oct 14, 2009 Female patient from UNITED STATES , child 10 years of age, was diagnosed with culture urine positive and was treated with Invanz (View Usage). After Invanz was administered, patient had the following side effects: platelet count decreased. Invanz dosage: 500 Mg/daily. Patient was hospitalized.

6551601-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Rash
on Nov 03, 2009 Male patient from UNITED STATES , 72 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Invanz (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, rash (What is rash?). Invanz dosage: 1 Gm/iv. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

6551517-5 | Hallucination
Patient was taking Invanz (View Usage). Patient had the following side effects: hallucination on Jun 26, 2009 from UNITED STATES Additional patient health information: Female patient , 65 years of age, was diagnosed with infection (What is infection?) and. Invanz dosage: 500 Mg/daily/iv. During the same period patient was treated with NEPHROCAPS (View Nephrocaps Review and Nephrocaps Label ), NORVASC (View Norvasc Review and Norvasc Label ), RENAGEL (View Renagel Review and Renagel Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CALCITRIOL (View Calcitriol Review and Calcitriol Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.